AlzChem Group (Germany) Today

ACT Stock  EUR 64.60  0.60  0.94%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 10

 
High
 
Low
Low
AlzChem Group is trading at 64.60 as of the 24th of January 2025, a 0.94 percent increase since the beginning of the trading day. The stock's lowest day price was 63.4. AlzChem Group has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of July 2024 and ending today, the 24th of January 2025. Click here to learn more.

Moving against AlzChem Stock

  0.58DBPD Xtrackers ShortDAXPairCorr
  0.49EII EisaiPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

AlzChem Group AG Risk Profiles

Although AlzChem Group's alpha and beta are two of the key measurements used to evaluate AlzChem Group's performance over the market, the standard measures of volatility play an important role as well.

AlzChem Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in AlzChem Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Other Information on Investing in AlzChem Stock

AlzChem Group financial ratios help investors to determine whether AlzChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.